These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33495505)

  • 21. An Improved Medium for Colistin Susceptibility Testing.
    Gwozdzinski K; Azarderakhsh S; Imirzalioglu C; Falgenhauer L; Chakraborty T
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.
    Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic
    Wu KC; Hua KF; Yu YH; Cheng YH; Cheng TT; Huang YK; Chang HW; Chen WJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
    Zhou YF; Tao MT; Feng Y; Yang RS; Liao XP; Liu YH; Sun J
    J Antimicrob Chemother; 2017 Jun; 72(6):1723-1730. PubMed ID: 28333193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting colistin susceptibility testing: will adding calcium to Mueller-Hinton agar improve the detection of colistin resistance?
    Matuschek E; Brolund A; Karlsson Lindsjö O; Giske CG; Byfors S; Kahlmeter G
    Clin Microbiol Infect; 2021 Aug; 27(8):1172.e1-1172.e5. PubMed ID: 33901665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of colistin resistance and mcr-1/mcr-2 genes in extended-spectrum β-lactamase/AmpC-producing Escherichia coli isolated from chickens in Canada, Senegal and Vietnam.
    Vounba P; Rhouma M; Arsenault J; Bada Alambédji R; Fravalo P; Fairbrother JM
    J Glob Antimicrob Resist; 2019 Dec; 19():222-227. PubMed ID: 31100501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.
    Xie M; Chen K; Chan EW; Chen S
    Microbiol Spectr; 2022 Jun; 10(3):e0093722. PubMed ID: 35467374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G; Samlioglu P; Atalay S; Kose S
    Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
    Personne Y; Curtis MA; Wareham DW; Waite RD
    J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence Determinants and Plasmid-Mediated Colistin Resistance
    Tartor YH; Gharieb RMA; Abd El-Aziz NK; El Damaty HM; Enany S; Khalifa E; Attia ASA; Abdellatif SS; Ramadan H
    Front Cell Infect Microbiol; 2021; 11():761417. PubMed ID: 34888259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.
    Gordon NC; Png K; Wareham DW
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5316-22. PubMed ID: 20876375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-sensitization of
    Zhang Q; Wang R; Wang M; Liu C; Koohi-Moghadam M; Wang H; Ho PL; Li H; Sun H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2119417119. PubMed ID: 35263219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
    Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
    BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
    Loose M; Naber KG; Hu Y; Coates A; Wagenlehner FME
    Int J Antimicrob Agents; 2018 Dec; 52(6):783-789. PubMed ID: 30138665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.
    Corvec S; Furustrand Tafin U; Betrisey B; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1421-7. PubMed ID: 23295934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abundance of Mobilized Colistin Resistance Gene (
    Das T; Islam MZ; Rana EA; Dutta A; Ahmed S; Barua H; Biswas PK
    Microb Drug Resist; 2021 Nov; 27(11):1585-1593. PubMed ID: 33909471
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens.
    Nguyen HT; Venter H; Veltman T; Williams R; O'Donovan LA; Russell CC; McCluskey A; Page SW; Ogunniyi AD; Trott DJ
    Int J Antimicrob Agents; 2021 May; 57(5):106323. PubMed ID: 33746046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics.
    MacNair CR; Stokes JM; Carfrae LA; Fiebig-Comyn AA; Coombes BK; Mulvey MR; Brown ED
    Nat Commun; 2018 Jan; 9(1):458. PubMed ID: 29386620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.